NCT07410000 Ultrasound-Guided Quadro-Iliac Plane Block for Pain Management After Total Hip Arthroplasty
| NCT ID | NCT07410000 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bursa City Hospital |
| Condition | Pain Management |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-03-16 |
| Primary Completion | 2027-02-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-03-16 with a primary completion date of 2027-02-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective, randomized, double-blind study evaluates the analgesic effectiveness of the ultrasound-guided Quadro-Iliac Plane (QIP) block in patients undergoing primary total hip arthroplasty. The QIP block is a recently described fascial plane block. Patients will be randomized to receive either a QIP block with local anesthetic or a sham block with saline. The primary outcome is 24-hour opioid consumption. Secondary outcomes include motor block, dermatomal sensory assessment, pain scores, rescue analgesic requirement, quality of recovery (QoR-15), and opioid-related side effects.
Eligibility Criteria
Inclusion Criteria: * American Society of Anesthesiologists (ASA) classification I-III * Age between 18 and 80 years * Patients scheduled for elective primary total hip arthroplasty Exclusion Criteria: * Refusal to participate in the study * Allergy to local anesthetics or opioids * Known or suspected coagulopathy * Infection at the injection site * History of previous hip surgery * Severe cardiovascular disease * Liver or kidney failure * Pregnancy, suspected pregnancy, or breastfeeding * Severe neurological or psychiatric disorder * Chronic opioid use
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07410000 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Pain Management. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07410000 currently recruiting?
Yes, NCT07410000 is actively recruiting participants. Contact the research team at drmurselekinci@gmail.com for enrollment information.
Where is the NCT07410000 trial being conducted?
This trial is being conducted at Bursa, Turkey (Türkiye).
Who is sponsoring the NCT07410000 clinical trial?
NCT07410000 is sponsored by Bursa City Hospital. The trial plans to enroll 100 participants.